CalciMedica (CALC) Profit After Tax (2019 - 2026)

CalciMedica (CALC) has 8 years of Profit After Tax data on file, last reported at $5.0 million in Q1 2026.

• Quarterly Profit After Tax rose 198.69% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.6 million (down 3.74% YoY) and the FY2025 annual result came in at -$29.6 million, down 116.06% from the prior year.
• Profit After Tax advanced to $5.0 million in Q1 2026, from -$10.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $5.0 million in Q1 2026 to a low of -$19.3 million in Q1 2023.
• A 5-year average of -$4.8 million and a median of -$4.3 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax plunged 4287.88% — and 2026, when it soared 198.69%.
• Tracing CALC's Profit After Tax over 5 years: stood at $99000.0 in 2022, then sank by 4287.88% to -$4.1 million in 2023, then retreated by 2.7% to -$4.3 million in 2024, then plunged by 153.59% to -$10.8 million in 2025, then surged by 146.08% to $5.0 million in 2026.
• The last three Profit After Tax figures came in at $5.0 million (Q1 2026), -$10.8 million (Q4 2025), and -$7.8 million (Q3 2025), per Business Quant data.